retatrutide trial VisualAbstract: reduces body weight by 17.5% in patients with obesity Retatrutide Shows 28.3% Weight Loss

Several well-established and widely prescribed GLP-1 receptor agonists, including various formulations of semaglutide, liraglutide, and dulaglutide, are administered via subcutaneous injection

Most physicians prescribe it as a morning dose, sometimes as a split dose with a smaller tablet taken in the early afternoon

This makes the 8mg/mL concentration impractical for patients who have titrated past the 7.5mg dose level

Avoiding certain foods is only one part of building a GLP-1-friendly diet

Contact your healthcare provider immediately or, if symptoms are severe, go directly to an emergency department for evaluation

Food and Drug Administration (FDA) approved specifically for fibromyalgia, this research may pave the way for new treatment guidelines and clinical trials